Supporting Evidence for an Active Treatment Program for Advanced Salivary Gland Carcinomas

Overview

Journal Cancer Treat Rep

Specialty Oncology

Date 1985 Mar 1

PMID 3884153

Citations 5

Authors

M A Eisenberger

Affiliations

Soon will be listed here.

Abstract

The role of systemic chemotherapy in the treatment of salivary gland tumors remains unknown. Because of the infrequent occurrence of these tumors, only a few clinical trials with chemotherapy have been reported in the literature. The current trial presents preliminary results with the combination of cyclophosphamide, doxorubicin, and cisplatin. These results are viewed in terms of other recently reported data obtained with the same combination. The collected data strongly suggest that salivary gland tumors may be very responsive to chemotherapy.

Citing Articles

Primary Ductal Her-2 Positive Adenocarcinoma of Salivary Gland: A Long Follow-Up Case Report and Review of the Literature.

Deantoni C, Midulla M, Mirabile A, Chiara A, Lucchini R, Giannini L Case Rep Ophthalmol Med. 2024; 2024:4410206.

PMID: 39301249 PMC: 11412745. DOI: 10.1155/2024/4410206.

Cisplatin in cancer therapy: molecular mechanisms of action.

Dasari S, Tchounwou P Eur J Pharmacol. 2014; 740:364-78.

PMID: 25058905 PMC: 4146684. DOI: 10.1016/j.ejphar.2014.07.025.

Systemic therapy in the management of metastatic or advanced salivary gland cancers.

Lagha A, Chraiet N, Ayadi M, Krimi S, Allani B, Rifi H Head Neck Oncol. 2012; 4:19.

PMID: 22558945 PMC: 3414773. DOI: 10.1186/1758-3284-4-19.

Chemotherapy for recurrent adeno- and adenoidcystic carcinomas in the head and neck.

Tsukuda M, Kokatsu T, Ito K, Mochimatsu I, Kubota A, Sawaki S J Cancer Res Clin Oncol. 1993; 119(12):756-8.

PMID: 8408188 DOI: 10.1007/BF01195348.

Chemotherapy for cranial base tumors.

Jacob H J Neurooncol. 1994; 20(3):327-35.

PMID: 7844625 DOI: 10.1007/BF01053047.